Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Korean Journal of Hematology ; : 150-153, 2012.
Artículo en Inglés | WPRIM | ID: wpr-720180

RESUMEN

Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.


Asunto(s)
Humanos , Persona de Mediana Edad , Células Presentadoras de Antígenos , Antígenos Comunes de Leucocito , Biopsia , Bleomicina , Dacarbazina , Sarcoma de Células Dendríticas Interdigitantes , Células Dendríticas , Cavidad Nasal , Proteínas S100 , Cornetes Nasales , Vinblastina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA